The novel therapy of tirzepatide peptide represents a significant breakthrough in the handling of the condition. Unlike existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide617402.designi1.com/62728029/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment